VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...
Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...
Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.
Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high.
The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...
Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.
We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through the clinic.
The week before the clocks change this March, Lisbon hosted BIO-Europe Spring 2026, Europe’s largest springtime biopharma partnering conference. The event brought together more than 3,700 innovators ...
More than 1.9 million new colorectal cancer cases were diagnosed in 2022, making it the third most common cancer type globally, and it was linked to more than 900,000 deaths that year. This makes ...
Iconic for the Grand Canyon and landscapes like Sedona’s red rocks, the American state’s income is mostly derived from the real estate industry. That’s not to say that sectors like healthcare and ...
Pfizer reaffirmed it is a household name through its partnership with BioNTech on the Pfizer-BioNTech COVID-19 vaccine, which received its first U.S. authorization from the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results